Literature DB >> 1899348

Enhancement of the fibrinolytic activity of sheep endothelial cells by retroviral vector-mediated gene transfer.

D A Dichek1, O Nussbaum, S J Degen, W F Anderson.   

Abstract

In an attempt to enhance the fibrinolytic activity of endothelial cells (EC), a retroviral vector containing the human tissue-type plasminogen activator (t-PA) cDNA was constructed. Sheep EC were stably transduced with the vector, resulting in a 30-fold increase in t-PA activity over that detected in EC transduced with a control vector. Southern and Northern analyses confirmed the presence of both the vector sequence and the appropriate mRNA transcripts. Secretion of high levels of recombinant human t-PA continued in vitro for the duration of the experiments, up to 11 weeks after transduction, although the rate of t-PA secretion decreased in some of the EC lines. Zymographic analysis of conditioned medium from t-PA-transduced EC showed the presence of two new molecular species with plasminogen activator activity that could be specifically immunoprecipitated with a monoclonal antihuman t-PA antibody. The relative molecular masses of these species (60 to 80 and 110 Kd) suggest that they represent recombinant human t-PA both free and bound to sheep plasminogen activator inhibitor 1 (PAI-1). Consistent with this interpretation, the 110-Kd species could be specifically immunoprecipitated with antiserum to PAI-1. These studies demonstrate that retroviral vector-mediated gene transfer may be used to increase total EC fibrinolytic activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1899348

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

Review 1.  Biologic alternatives to stents and grafts.

Authors:  N M Caplice
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 2.931

2.  Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells.

Authors:  P Lemarchand; H A Jaffe; C Danel; M C Cid; H K Kleinman; L D Stratford-Perricaudet; M Perricaudet; A Pavirani; J P Lecocq; R G Crystal
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

3.  Human macrovascular endothelial cells: optimization of culture conditions.

Authors:  T T Terramani; D Eton; P A Bui; Y Wang; F A Weaver; H Yu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-02       Impact factor: 2.416

4.  Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B.

Authors:  S N Yao; J M Wilson; E G Nabel; S Kurachi; H L Hachiya; K Kurachi
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

5.  Long-term expression of human adenosine deaminase in vascular smooth muscle cells of rats: a model for gene therapy.

Authors:  C M Lynch; M M Clowes; W R Osborne; A W Clowes; A D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

6.  High-level expression of recombinant human tPA in cultivated canine endothelial cells under varying conditions of retroviral gene transfer.

Authors:  R M Podrazik; T A Whitehill; D Ekhterae; W D Williams; L M Messina; J C Stanley
Journal:  Ann Surg       Date:  1992-10       Impact factor: 12.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.